Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities
Net income	$ 177,527	$ 117,391
Adjustments to net income:
Depreciation and amortization	148,656	128,602
Amortization of deferred financing costs and other noncash interest expense	5,184	4,698
Amortization of equity-based compensation	6,477	17,694
Provisions for impairment	6,212	13,950
Net gain on dispositions of real estate	(19,732)	(21,550)
Loss from non-real estate, equity method investments	3,332	1,068
Distributions received from non-real estate, equity method investment	468
Noncash revenue and other	(2,460)	(5,436)
Changes in operating assets and liabilities:
Other assets	8,145	10,666
Accrued expenses, deferred revenue and other liabilities	(5,944)	(1,791)
Net cash provided by operating activities	327,865	265,292
Investing activities
Acquisition of and additions to real estate	(834,645)	(570,156)
Investment in loans and financing receivables	(62,369)	(44,933)
Collections of principal on loans and financing receivables	49,968	6,691
Proceeds from dispositions of real estate	117,239	172,492
Contributions made to non-real estate, equity method investment	(468)
Net cash used in investing activities	(730,275)	(435,906)
Financing activities
Borrowings under credit facility	343,000	279,000
Repayments under credit facility	(428,000)	(279,000)
Borrowings under unsecured notes and term loans payable	600,000
Repayments under unsecured notes and term loans payable		100,000
Borrowings under non-recourse debt obligations of consolidated special purpose entities		514,785
Repayments under non-recourse debt obligations of consolidated special purpose entities	(176,214)	(116,447)
Financing costs paid	(3,024)	(10,755)
Proceeds from the issuance of common stock	252,873	172,372
Stock issuance costs paid	(3,268)	(2,931)
Shares repurchased under stock compensation plans	(6,271)	(9,345)
Dividends paid	(214,331)	(195,396)
Net cash provided by financing activities	364,765	252,283
Net (decrease) increase in cash, cash equivalents and restricted cash	(37,645)	81,669
Cash, cash equivalents and restricted cash, beginning of period	70,049	176,576
Cash, cash equivalents and restricted cash, end of period	32,404	258,245
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	30,855	168,567
Restricted cash included in other assets	1,549	89,678
Total cash, cash equivalents and restricted cash	32,404	258,245
Supplemental disclosure of noncash investing and financing activities:
Accrued tenant improvements included in real estate investments	17,593	15,484
Acquisition of real estate assets from borrowers under loans and financing receivables	8,945	35,384
Accrued financing and stock issuance costs	66	209
Supplemental disclosure of cash flow information:
Cash paid during the period for interest, net of amounts capitalized	83,631	79,088
Cash paid during the period for income and franchise taxes	$ 2,183	$ 1,859